摘要
血肿的体积在自发性脑出血的死亡和预后中是一个最强的独立的预示因子,降低血肿的扩大是一个有效的干预靶点。目前的治疗方法主要有降低血压和重组体活化凝血因子VⅡa的使用,但它们对预后的影响仍然需要进一步的证实。干细胞治疗已经为患者更好的功能性恢复带来了希望。
Hematoma volume following spontaneous intracerebral hemorrhage is the strongest single predictor of mortality and outcome, and reducing the enlargement of intracerebral hemorrhage is an effective treatment target.Currently existing therapies for ICH expansion are mainly the administration of lowering blood pressure and recombinant activated factor VⅡ a, which their effect on outcome need further confirmation.Stem cell therapy has shown promise for better functional recovery.
出处
《中外医学研究》
2012年第32期153-156,共4页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
脑出血
中风
血肿的扩大
治疗
Intracerebral hemorrhage
Stroke
Hematoma enlargement
Treatment
